MedTrace Logo

A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for Atrial Fibrillation

NCT00192972 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2005-12-22

No results posted yet for this study

Summary

Both segmental, ostial and circumferential, extra-ostial pulmonary vein (PV) isolation have been proven effective in the treatment of atrial fibrillation.

In this study patients with symptomatic paroxystic or persistent AF were randomised to one of the above mentioned ablation methods. The primary endpoints were recurrent AF and recurrence of left atrium-PV conduction.

Conditions

Interventions

PROCEDURE

Catheter ablation (pulmonary vein isolation)

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Biosense Webster, Inc.

    collaborator INDUSTRY

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Guidant Corporation

    collaborator INDUSTRY

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Brian Nilsson, MD · Rigshospitalet, Denmark

  • Xu Chen, MD · Righospitalet, Copenhagen, Denmark

  • Steen M Pehrson, MD · Righospitalet, Copenhagen, Denmark

  • Lars Køber, MD · Righospitalet, Copenhagen, Denmark

  • Jørgen Hilden, MD · Department of biostatistics, University of Copenhagen

  • Jesper H Svendsen, MD · Righospitalet, Copenhagen, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
ECT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-11-30
Completion
2005-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00192972 on ClinicalTrials.gov